Practice Management

Payment Terms for Aflibercept Injection Extended in Response to COVID-19

Regeneron will temporarily extend physician payment terms from 100 days to 150 days for Eylea (aflibercept) Injection purchases from authorized distributors due to the COVID-19 outbreak, according to a press release by the American Academy of Ophthalmology. The new temporary terms are expected to be implemented by April 1, 2020 and...